Literature DB >> 23871623

Levosimendan reverted severe pulmonary hypertension in one patient on waiting list for heart transplantation.

Enrico Ammirati1, Francesco Musca, Fabrizio Oliva, Andrea Garascia, Valentina Pacher, Alessandro Verde, Manlio Cipriani, Antonella Moreo, Luigi Martinelli, Maria Frigerio.   

Abstract

Entities:  

Keywords:  Heart failure; Heart transplantation; Levosimendan; Pulmonary hypertension; Right ventricle

Mesh:

Substances:

Year:  2013        PMID: 23871623     DOI: 10.1016/j.ijcard.2013.06.106

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  2 in total

1.  Acute effects of levosimendan in experimental models of right ventricular hypertrophy and failure.

Authors:  Mads D Vildbrad; Asger Andersen; Sarah Holmboe; Steffen Ringgaard; Jan M Nielsen; Jens Erik Nielsen-Kudsk
Journal:  Pulm Circ       Date:  2014-09       Impact factor: 3.017

2.  Comparison of levosimendan, NO, and inhaled iloprost for pulmonary hypertension reversibility assessment in heart transplant candidates.

Authors:  Marta Tavares-Silva; Francisca Saraiva; Roberto Pinto; Sandra Amorim; João Carlos Silva; Adelino F Leite-Moreira; Maria Júlia Maciel; André P Lourenço
Journal:  ESC Heart Fail       Date:  2021-02-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.